329 related articles for article (PubMed ID: 31652997)
21. Therapeutic effects of the rhSOD2-Hirudin fusion protein on bleomycin-induced pulmonary fibrosis in mice.
Shen L; Lei S; Huang L; Li S; Yi S; Breitzig M; Huang M; Mo X; Sun H; Zheng Q; Tian J; Czachor A; Wang F
Eur J Pharmacol; 2019 Jun; 852():77-89. PubMed ID: 30831079
[TBL] [Abstract][Full Text] [Related]
22. The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis : Cilengitide and Bleomycin-Induced Pulmonary Fibrosis.
Ritzenthaler JD; Zhang M; Torres-Gonzalez E; Roman J
Lung; 2020 Dec; 198(6):947-955. PubMed ID: 33146772
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice.
Wang L; Wang Y; Yang T; Guo Y; Sun T
Cell Physiol Biochem; 2015; 36(2):697-711. PubMed ID: 25998889
[TBL] [Abstract][Full Text] [Related]
24. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
25. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
[TBL] [Abstract][Full Text] [Related]
27. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
28. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
Kimura T; Nojiri T; Hino J; Hosoda H; Miura K; Shintani Y; Inoue M; Zenitani M; Takabatake H; Miyazato M; Okumura M; Kangawa K
Respir Res; 2016 Feb; 17():19. PubMed ID: 26895702
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
[TBL] [Abstract][Full Text] [Related]
30. FTY720 attenuates paraquat-induced lung injury in mice.
Qian J; Ye Y; Lv L; Zhu C; Ye S
Int Immunopharmacol; 2014 Aug; 21(2):426-31. PubMed ID: 24893116
[TBL] [Abstract][Full Text] [Related]
31. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.
Kishi M; Aono Y; Sato S; Koyama K; Azuma M; Abe S; Kawano H; Kishi J; Toyoda Y; Okazaki H; Ogawa H; Uehara H; Nishioka Y
PLoS One; 2018; 13(12):e0209786. PubMed ID: 30596712
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina.
Yang QH; Zhang Y; Jiang J; Wu MM; Han Q; Bo QY; Yu GW; Ru YS; Liu X; Huang M; Wang L; Zhang XM; Fang JM; Li XR
Int J Ophthalmol; 2018; 11(6):935-944. PubMed ID: 29977804
[TBL] [Abstract][Full Text] [Related]
33. [Effects of interleukin-11 antagonist on pulmonary fibrosis in mice].
Wu LX; Wu X
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 May; 37(3):308-312. PubMed ID: 34374245
[No Abstract] [Full Text] [Related]
34. Sodium Arsenite Inhibits Lung Fibroblast Differentiation and Pulmonary Fibrosis.
Jiao H; Song J; Sun X; Sun D; Zhong M
Pharmacology; 2019; 104(5-6):368-376. PubMed ID: 31553994
[TBL] [Abstract][Full Text] [Related]
35. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
37. Essential oil from Inula japonica Thunb. And its phenolic constituents ameliorate pulmonary injury and fibrosis in bleomycin-treated mice.
Wei F; Yin Y; Li J; Chang Y; Zhang S; Zhao W; Ma X
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117169. PubMed ID: 37704119
[TBL] [Abstract][Full Text] [Related]
38. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
39. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P
Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334
[TBL] [Abstract][Full Text] [Related]
40. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
